These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26353179)

  • 21. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
    Zheng MM; Yue LJ; Chen XW; Wen FQ; Li CG; Yang CL; Xie C; Ding H
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
    Krajinovic M; Elbared J; Drouin S; Bertout L; Rezgui A; Ansari M; Raboisson MJ; Lipshultz SE; Silverman LB; Sallan SE; Neuberg DS; Kutok JL; Laverdière C; Sinnett D; Andelfinger G
    Pharmacogenomics J; 2016 Nov; 16(6):530-535. PubMed ID: 26345518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
    Seidemann K; Book M; Zimmermann M; Meyer U; Welte K; Stanulla M; Reiter A
    Ann Hematol; 2006 May; 85(5):291-300. PubMed ID: 16463153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia.
    Liu Y; Yin Y; Sheng Q; Lu X; Wang F; Lin Z; Tian H; Xu A; Zhang J
    PLoS One; 2014; 9(1):e82681. PubMed ID: 24404132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
    van Kooten Niekerk PB; Schmiegelow K; Schroeder H
    Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia.
    Gregers J; Gréen H; Christensen IJ; Dalhoff K; Schroeder H; Carlsen N; Rosthoej S; Lausen B; Schmiegelow K; Peterson C
    Pharmacogenomics J; 2015 Aug; 15(4):372-9. PubMed ID: 25582575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of thymidylate synthase gene polymorphisms on high-dose methotrexate-related toxicities in childhood acute lymphoblastic leukemia].
    Zhu XJ; He XL; Wu YP; Zou RY; Li WL; Zou H; You YL; Liu H; Tian X
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):11-4. PubMed ID: 25616285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acral erythema with oral methotrexate in a child.
    Varela CR; McNamara J; Antaya RJ
    Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia.
    Ansari M; Sauty G; Labuda M; Gagné V; Rousseau J; Moghrabi A; Laverdière C; Sinnett D; Krajinovic M
    Pharmacogenomics J; 2012 Oct; 12(5):386-94. PubMed ID: 21606946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia.
    Taub JW; Matherly LH; Ravindranath Y; Kaspers GJ; Rots MG; Zantwijk CH
    Leukemia; 2002 Apr; 16(4):764-5. PubMed ID: 11960366
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia.
    Kodidela S; Pradhan SC; Dubashi B; Basu D
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1349-58. PubMed ID: 26335211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.
    Ansari M; Sauty G; Labuda M; Gagné V; Laverdière C; Moghrabi A; Sinnett D; Krajinovic M
    Blood; 2009 Aug; 114(7):1383-6. PubMed ID: 19515727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.
    Gervasini G; de Murillo SG; Jiménez M; de la Maya MD; Vagace JM
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):589-595. PubMed ID: 28719513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate.
    Niedzielska E; Węcławek-Tompol J; Matkowska-Kocjan A; Chybicka A
    Adv Clin Exp Med; 2013; 22(4):579-84. PubMed ID: 23986219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia.
    Gurieva OD; Savelyeva MI; Valiev TT; Sozaeva ZA; Kondratenko SN; Ilyin MV
    Drug Metab Pers Ther; 2023 Dec; 38(4):349-357. PubMed ID: 38098143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology.
    Starý J; Gajdos P; Hrstková H; Blazek B; Slavík Z; Mihál V; Zahálka F; Jabali Y; Vávra V; Kopecná L; Mydlil J; Trka J
    Med Pediatr Oncol; 2002 Aug; 39(2):125-7. PubMed ID: 12116061
    [No Abstract]   [Full Text] [Related]  

  • 37. A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.
    Foster JH; Thompson PA; Bernhardt MB; Margolin JF; Hilsenbeck SG; Jo E; Marquez-Do DA; Scheurer ME; Schafer ES
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):349-360. PubMed ID: 30488179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.
    Treviño LR; Shimasaki N; Yang W; Panetta JC; Cheng C; Pei D; Chan D; Sparreboom A; Giacomini KM; Pui CH; Evans WE; Relling MV
    J Clin Oncol; 2009 Dec; 27(35):5972-8. PubMed ID: 19901119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
    Tsao TF; Chao YH
    Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.
    Gabor KM; Schermann G; Lautner-Csorba O; Rarosi F; Erdelyi DJ; Endreffy E; Berek K; Bartyik K; Bereczki C; Szalai C; Semsei AF
    Pediatr Blood Cancer; 2015 Apr; 62(4):622-8. PubMed ID: 25557962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.